Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Mucopolysaccharidosis III
NCT04018755Phase 2Completed
- Start
- Jan 2020
- Primary completion
- Jul 2022
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in mucopolysaccharidosis type III. Started Jan 2020; status: completed.
02
Drugs
anakinra
03
Conditions
mucopolysaccharidosis type III
Beyond the preview
Go deeper on NCT04018755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04018755.